Franck Rahaghi, M.D.
| Appointed: |
2003 |
| Gender: |
Male |
| Languages: |
English
French
Persian |
Pulmonary Disease (Weston)
Biographical Sketch
Franck Rahaghi, MD, MH, FCCP, is Chair of Quality at Cleveland Clinic Florida Hospital and Clinic. He has also been Medical Director of the Respiratory Care Department since 2003.
In 2003, Dr. Rahaghi became Staff Attending in Pulmonary Critical Care as well as Director of the Pulmonary Hypertension Clinic, Cleveland Clinic Florida. In 2005, he became Head of the Pulmonary Education and Rehabilitation Department as well as a member of the Internal Review Board, responsible for correct conduct of research and clinical trials at Cleveland Clinic Florida. In the following year, he was named Director of Quality and Outcomes Development in the Division of Medicine.
Formerly, Dr. Rahaghi was a Fellow in Medicine/Pulmonary/Critical Care at New York Presbyterian-Weill Cornell Medical Center in New York City (1999-2003). He was also an Instructor in genetic medicine at the Cornell University Weill School of Medicine (2001-2003) and assisted in the design and implementation of clinical trials at Cornell (Activated Protein C and IFN gamma-1b) (2000-2003).
In 1999, he was a Visiting Associate Physician at Rockefeller University Hospital, New York, N.Y. He participated in the Categorical Internal Medicine Program at the University of Illinois at Chicago from 1997-1999. From 1996-1997, he participated in the Categorical Internal Medicine Program.at the University of Minnesota, Minn. In 2000, he became a Hospitalist at Sharp Memorial Hospital, San Diego. The following year, he was a Visitor at the University of California-San Diego Interventional Pulmonology Department/Pulmonary Hypertension.
Professional Highlights
- Expert in pulmonary hypertension, serving South Florida (Broward and Palm Beaches)
- Head of the first comprehensive Pulmonary Education Department
- Chair of Quality in Cleveland Clinic Florida, advancing outcome-based improvements in quality
Education & Fellowships
| Medical School: | University of California San Francisco Medical Center, San Francisco, CA |
|
| Internship: | University of Minnesota Medical School, Internal Medicine, Minneapolis, MN |
| Residency: | University of Illinois at Chicago Hospitals, Internal Medicine, Chicago, IL |
| Fellowship: | New York Presbyterian Hospital, Columbia Presbyterian Campus, Pulmonary&Critical Care, New York, NY |
Additional Training
- Enhancing Team Effectiveness, professional development program for health professions faculty, jointly sponsored by the Association of American Medical Colleges and Harvard Medical School
- Cleveland Clinic Leadership Course, Cleveland Clinic, 2006
- Advanced Training in Quality, American College of Executive Physicians
Certifications
Critical Care Medicine
Pulmonary Disease
Internal Medicine
Specialty Interests
Pulmonary hypertension, Alpha-1 anti-trypsin deficiency/COPD, interstitial lung diseases, including: collagen vascular diseases and pulmonary fibrosis, critical care.
Innovations & Patents
Convertible dual-lumen endotracheal tube: U.S. Patent Pending, 2005
Awards & Honors
- Innovator Award, Cleveland Clinic, for innovation in medical technology, 2005-2007
- Leadership Certificate, Cleveland Clinic (promising future leaders at Cleveland Clinic), 2006
- Fellow, American College of Chest Physicians, 2005
- Cornell Award for Best Fellow Research, 2004
Professional Memberships
- College of Chest Physicians
- Society of Critical Care Medicine
- Pulmonary Hypertension Association/Research
- American Medical Association
- American Society of Executive Physicians,Vanguard Member
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Rahaghi has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Rahaghi receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Actelion
- Baxter Healthcare Corporation
- Gilead Sciences, Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
